Medicare Enrolled

Dr. Karla Madalin, MD

Neurology · Ravenna, OH
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
6847 N CHESTNUT ST STE 325, Ravenna, OH 44266
3302972401
In practice since 2006 (20 years)
NPI: 1194786822 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Madalin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Madalin? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Madalin

Dr. Karla Madalin is a neurology specialist in Ravenna, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Madalin performed 54 Medicare services across 47 unique beneficiaries.

Between the years covered by Open Payments, Dr. Madalin received a total of $6,007 from 47 pharmaceutical and/or device companies across 211 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Madalin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 54 Medicare services $6,007 industry payments

Medicare Practice Summary

Medicare Utilization ↗
54
Medicare services
Bottom 10% in OH for neurology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
47
Unique beneficiaries
$81
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~3 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
 30 $97 $223
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
 24 $62 $115
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2023 ↗
$6,007
Total received (2018-2023)
Avg $1,001/year across 6 years
Top 29% in OH for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
211
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,992 (99.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$16 (0.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2023
$116
2022
$345
2021
$846
2020
$440
2019
$2,270
2018
$1,990

Payments by company (2023)

Consulting
Speaking
Meals & Travel
Research
ARGENX US, INC.
$59
SK Life Science, Inc.
$21
PFIZER INC.
$20
Amneal Pharmaceuticals LLC
$16
Top 3 companies account for 86.2% of 2023 payments
All-time payments by company (2018-2023) ›
Biogen, Inc.
$948
Teva Pharmaceuticals USA, Inc.
$744
Novartis Pharmaceuticals Corporation
$518
Amgen Inc.
$500
GENZYME CORPORATION
$459
Alexion Pharmaceuticals, Inc.
$276
E.R. Squibb & Sons, L.L.C.
$219
US WorldMeds, LLC
$197
UCB, Inc.
$189
Genentech USA, Inc.
$163
SK Life Science, Inc.
$137
EMD Serono, Inc.
$131
Lilly USA, LLC
$126
Adamas Pharmaceuticals, Inc.
$117
Abbott Laboratories
$105
EISAI INC.
$95
Supernus Pharmaceuticals, Inc.
$90
Avanir Pharmaceuticals, Inc.
$88
Bausch Health US, LLC
$87
Vertical Pharmaceuticals, LLC
$63
Amneal Pharmaceuticals LLC
$60
ARGENX US, INC.
$59
Lundbeck LLC
$53
Neurocrine Biosciences, Inc.
$52
Biohaven Pharmaceuticals, Inc.
$46
AbbVie Inc.
$42
UPSHER-SMITH LABORATORIES LLC
$38
Bayer HealthCare Pharmaceuticals Inc.
$38
BOSTON SCIENTIFIC CORPORATION
$36
GE HEALTHCARE
$27
HARMONY BIOSCIENCES LLC
$24
ABBVIE INC.
$22
Aprecia Pharmaceuticals, LLC
$22
Celgene Corporation
$21
Horizon Therapeutics plc
$20
PFIZER INC.
$20
Mallinckrodt Enterprises LLC
$19
Almatica Pharma LLC
$18
Jazz Pharmaceuticals Inc.
$17
Promius Pharma LLC
$17
Kyowa Kirin, Inc.
$16
Acorda Therapeutics, Inc
$16
JAZZ PHARMACEUTICALS INC.
$16
Allergan, Inc.
$15
GRT US Holding, Inc.
$13
Upsher-Smith Laboratories LLC
$13
GE HealthCare
$12
Top 3 companies account for 36.8% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AIMOVIG · AJOVY · APOKYN · AUBAGIO · AUSTEDO · Aimovig · BOTOX · Betaseron · Briviact · COMIRNATY · COPAXONE · EMGALITY · Fycompa · GILENYA · GOCOVRI · GRALISE · INBRIJA · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · LEMTRADA · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · NORTHERA · NOURIANZ · NUEDEXTA · NURTEC ODT · None · OCREVUS · ONFI · OSMOLEX ER · QULIPTA · Qutenza · RYTARY · Rebif · SOLIRIS · Soliris · Spritam · TECFIDERA · TOPIRAMATE Extended Release Capsules · TOSYMRA · TROKENDI XR · TYSABRI · UBRELVY · UPLIZNA · VERCISE · VUMERITY · VYVGART · Vimpat · Wakix · XCOPRI · XYREM · Xadago · Xyrem · ZEPOSIA · Zembrace
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a neurology specialist in Ravenna?
Compare neurologists in the Ravenna area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
31
Per 100K population
19.2
County median income
$72,822
Nearest hospital
UNIVERSITY HOSPITALS PORTAGE MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data ✓ Medicare Util. Annual (CY lag)
Industry Payments ✓ Open Payments CY 2023
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Madalin is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Madalin experienced with initial hospital admission, moderate complexity?
Based on Medicare claims data, Dr. Madalin performed 30 initial hospital admission, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Madalin receive payments from pharmaceutical companies?
Yes. Dr. Madalin received a total of $6,007 from 47 companies across 211 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Madalin's costs compare to other neurologists in Ravenna?
Dr. Madalin's average Medicare payment per service is $81. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Madalin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Ravenna
Browse neurologists in Ravenna ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in OH
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in OH
Which OH neurologists receive the most from drug and device companies.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →